ESR2 and cancer: Hopefully, the data summarized here will help researchers avoid the use of poorly specific antibodies and lead to a lesser discrepancy of the obtained results, to better understand the role of ERβ and its variants in cancer progression and, finally, to correctly use ERβ as a biomarker.